Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Molecules (Basel, Switzerland)|September 13, 2025
Metabolism, a Blossoming Target for Small-Molecule Anticancer DrugsMichela Puxeddu, Romano Silvestri, Giuseppe La Regina
Molecules (Basel, Switzerland)|October 16, 2024
Targeting CBP and p300: Emerging Anticancer AgentsDomiziana Masci, Michela Puxeddu, Romano Silvestri, et al.
Molecules (Basel, Switzerland)|May 11, 2024
Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer TherapyDomiziana Masci, Michela Puxeddu, Romano Silvestri, et al.
Molecules (Basel, Switzerland)|December 24, 2021
Emerging Therapeutic Agents for Colorectal CancerMarianna Nalli, Michela Puxeddu, Giuseppe La Regina, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 13, 2023
Chemo- and enantio-selective reversed-phase HPLC analysis of rosuvastatin using a cellulose-based chiral stationary phase in gradient elution modeFrancesca Romana Mammone, Paola Rotundo, Rosella Ferretti, et al.
Molecules (Basel, Switzerland)|November 25, 2023
Recent Advances in Drug Discovery for Triple-Negative Breast Cancer TreatmentDomiziana Masci, Chiara Naro, Michela Puxeddu, et al.
Molecules (Basel, Switzerland)|January 8, 2023
A Novel Validated UHPLC Method for the Estimation of Rosuvastatin and Its Complete Impurity Profile in Tablet FormulationsFrancesca Romana Mammone, Leo Zanitti, Michela Puxeddu, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Discovery of New 1,1'-Biphenyl-4-sulfonamides as Selective Subnanomolar Human Carbonic Anhydrase II InhibitorsGiuseppe La Regina, Michela Puxeddu, Marianna Nalli, et al.
Chemmedchem|September 18, 2020
Sulfonamide Inhibitors of β-Catenin Signaling as Anticancer Agents with Different Output on c-MYCLaura Di Magno, Fiorella Di Pastena, Michela Puxeddu, et al.
Pageof 3